Syntekabio Stock Price at 18,850 Won (30.0%)... Bulletin Board Buzzing
At this time, posts about Syntekabio are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 25,000 shares of Syntekabio, and institutions have sold a net 4,000 shares, according to preliminary estimates. Syntekabio is known as a genomic big data research company.
As of 11:30 AM on the 3rd, Syntekabio's stock price is 18,850 KRW, up 30.0% from the previous day, with a trading volume of 8,196,721 shares, which is 887.97% of the 5-day average trading volume. On August 28, Syntekabio was an issue in the market with the news of discovering a COVID-19 treatment in collaboration with Actoris, described as "strong performance."
In addition to Syntekabio, posts by investors are also rapidly increasing for Ssangyong Cement Preferred (003415), Daebong LS (078140), and Philocis Healthcare (057880).
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- Businessman Sentenced to 3 Years for Embezzling 6.6 Billion Won to a 'Virtual Shaman'
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
